Haisco (002653.SZ): The innovative drug HSK47388 tablet has been granted FDA approval to conduct clinical trials.

Zhitong Finance and Economics APP News, Hisilicon (002653.SZ) recently disclosed that it has received a Study May Proceed Letter from the US Food and Drug Administration (FDA). According to FDA regulations, after review, the clinical trial application for HSK47388 tablets submitted by the company in May 2025 meets the relevant requirements for drug registration, and the product is approved to conduct clinical trials.